Castellano, T., Bae-Jump, V., Secord, A. A., Danziger, N., Graf, R., Quintanilha, J. C. F., … Pothuri, B. (2023). Liquid biopsy for advanced endometrial cancer: Prognostic value of plasma circulating DNA fraction in real-world settings (1320). In Gynecologic Oncology (Vol. 176, pp. S194–S195). Elsevier BV. https://doi.org/10.1016/j.ygyno.2023.06.221

Castellano, Tara, Victoria Bae-Jump, Angeles Alvarez Secord, Natalie Danziger, Ryon Graf, Julia C. F. Quintanilha, Gerald Li, et al. “Liquid biopsy for advanced endometrial cancer: Prognostic value of plasma circulating DNA fraction in real-world settings (1320).” In Gynecologic Oncology, 176:S194–95. Elsevier BV, 2023. https://doi.org/10.1016/j.ygyno.2023.06.221.

Castellano T, Bae-Jump V, Secord AA, Danziger N, Graf R, Quintanilha JCF, et al. Liquid biopsy for advanced endometrial cancer: Prognostic value of plasma circulating DNA fraction in real-world settings (1320). In: Gynecologic Oncology. Elsevier BV; 2023. p. S194–5.

Castellano, Tara, et al. “Liquid biopsy for advanced endometrial cancer: Prognostic value of plasma circulating DNA fraction in real-world settings (1320).” Gynecologic Oncology, vol. 176, Elsevier BV, 2023, pp. S194–95. Crossref, doi:10.1016/j.ygyno.2023.06.221.

Castellano T, Bae-Jump V, Secord AA, Danziger N, Graf R, Quintanilha JCF, Li G, Decker B, Lin D, Elvin J, Pothuri B. Liquid biopsy for advanced endometrial cancer: Prognostic value of plasma circulating DNA fraction in real-world settings (1320). Gynecologic Oncology. Elsevier BV; 2023. p. S194–S195.